In the last several decades, numerous attempts have been made to find effective therapeutic drugs for DM, and the known therapeutic targets, α-glucosidase and protein tyrosine phosphatase 1B (PTP1B), have drawn the attention of many scientists. Here, PTPN1 is linked to diabetes mellitus.